Dr. Niihara Feted by Indian Government in Recognition of the Development of Endari®
TORRANCE, Calif., Dec. 19, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), announced today that Dr. Yutaka Niihara, Chairman and Chief Executive Officer of the company, was feted at an event held on December 16, 2022 at the World Trade Center in Mumbai, India by the Minister of State of India, Arun Halder, in recognition of Dr. Niihara's work in developing Endari® to treat sickle cell disease (SCD). The event was hosted by Dr. Aviti Govatikar, a medical doctor and former Mrs. World.
- The event was hosted by Dr. Aviti Govatikar, a medical doctor and former Mrs. World.
- Underprivileged tribal communities in India are disproportionately affected by SCD because of a lack of treatments and resources.
- There are approximately 100,000 people living with sickle cell disease (SCD) in the United States and millions more globally.
- 2Source: Committee on Addressing Sickle Cell Disease – A Strategic Plan and Blueprint for Action -- National Academy of Sciences Press, 2020.